Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open‐label, single‐arm phase II …
V Srimuninnimit, V Sriuranpong… - Asia‐Pacific Journal of …, 2014 - Wiley Online Library
Aims Currently, the only standard systemic treatment for advanced hepatocellular carcinoma
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II …
V Srimuninnimit, V Sriuranpong… - Asia Pacific Journal of …, 2014 - search.ebscohost.com
Aims Currently, the only standard systemic treatment for advanced hepatocellular carcinoma
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: a multicenter, open-label, single-arm phase II …
V Srimuninnimit, V Sriuranpong… - Asia-Pacific journal …, 2014 - pubmed.ncbi.nlm.nih.gov
Aims Currently, the only standard systemic treatment for advanced hepatocellular carcinoma
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open‐label, single‐arm phase II …
V Srimuninnimit, V Sriuranpong… - Asia‐Pacific Journal of …, 2014 - infona.pl
Aims Currently, the only standard systemic treatment for advanced hepatocellular carcinoma
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: a multicenter, open-label, single-arm phase II …
V Srimuninnimit, V Sriuranpong… - Asia-pacific Journal of …, 2014 - europepmc.org
Aims Currently, the only standard systemic treatment for advanced hepatocellular carcinoma
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …
is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the …